ArticleEuropean journal of haematology2023

Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia.

Mario Tiribelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.